Investor Overview
Neordent is building an oral-intelligence ecosystem at the intersection of oral health, cardiometabolic risk, and connected devices. GentleDental.ai transforms everyday brushing into a continuous wellness signal, creating a defensible, data-rich layer in preventive healthcare.
We are positioning GentleDental.ai as a premium, clinically grounded wellness platform with clear regulatory and IP roadmaps.
Unit Economics & Business Model Direction
Neordent is pursuing a hybrid hardware + subscription SaaS model designed for recurring revenue and scalable unit economics.
• Alpha BOM structured for cost optimization and scale
• Target premium ASP of ~₹5,500 in India
• Hardware sale coupled with GentleDental.ai platform access
• Dentist SaaS for clinics and dental partners
Investment Snapshot
Lead Investor
ABGD Holdings LLC (USA)
Instrument
Compulsorily Convertible Debentures (CCD)
Investment Amount
₹60 Lakhs
Conversion Terms
30% discount at conversion
Board Composition
2 Promoter Directors + 2 ABGD nominee directors
Why This Market
Preventive healthcare is shifting from episodic visits to continuous, data-driven monitoring, with consumers increasingly comfortable with home-based diagnostics and AI-guided wellness.
Preventive healthcare TAM is expanding globally
Consumer diagnostics and home-based monitoring are converging
AI-driven wellness and personalization are becoming mainstream
Oral–systemic links between inflammation and cardiometabolic disease are increasingly validated
Investor & Partnership Enquiries
For investors, strategic partners, and ecosystem collaborators, please share a brief note about your interest. We will respond with relevant information and materials.